1. Home
  2. GOVX vs CMND Comparison

GOVX vs CMND Comparison

Compare GOVX & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

N/A

Current Price

$0.17

Market Cap

3.0M

Sector

Health Care

ML Signal

N/A

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

N/A

Current Price

$5.85

Market Cap

3.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GOVX
CMND
Founded
2001
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
3.2M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
GOVX
CMND
Price
$0.17
$5.85
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $10.00
N/A
AVG Volume (30 Days)
★ 111.0K
14.1K
Earning Date
11-12-2026
09-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $2,489,145.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.17
$0.07
52 Week High
$1,425.00
$7.16

Technical Indicators

Market Signals
Indicator
GOVX
CMND
Relative Strength Index (RSI) 8.96 67.16
Support Level N/A $0.66
Resistance Level $8.64 $7.16
Average True Range (ATR) 0.16 0.31
MACD -0.15 -0.17
Stochastic Oscillator 0.00 33.33

Price Performance

Historical Comparison
GOVX
CMND

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Share on Social Networks: